Which new Indian antibiotic has been developed to treat drug-resistant respiratory tract infections ?
Nafithromycin
Nafithromycin is the new antibiotic developed in India for drug-resistant respiratory tract infections. It was produced by Wockhardt with support from the Biotechnology Industry Research Assistance Council and marketed as Miqnaf.
It belongs to the lactone ketolide class and acts on the bacterial ribosome, which allows it to work against strains of community-acquired bacterial pneumonia that no longer respond to older macrolides such as azithromycin. A short three-day course is enough, which also helps patients complete treatment.
The other names are not new Indian antibiotics for this purpose. Favipiravir and Remdesivir are antiviral drugs, not antibacterials, and azithromycin is precisely the older macrolide to which resistance had been rising.
Hence, the answer is Nafithromycin.
Similar Questions
Which indigenous Automatic Train Protection (ATP) system has been developed by India to enhance railway safety ?
Which US-based AST SpaceMobile communication satellite did ISRO launch from Sriharikota (Andhra Pradesh) in 2025 ?
Important Questions from Science Technology and Inventions
- Which one of the following statements with respect to Global Positioning System (GPS) is not correct?
Who among the following invented the powerloom that revolutionized the cotton textile industry?
Which one of the following is the name given to the Lander of Chandrayaan-2?
Which was the first Indian Satellite named after Indian mathematician launched in 1975 by the Soviet Union?
Which of the followings has been dubbed as ‘India's maiden human spaceflight programme’?
